BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23995792)

  • 1. The Ras-ERK pathway modulates cytoskeleton organization, cell motility and lung metastasis signature genes in MDA-MB-231 LM2.
    Choi C; Helfman DM
    Oncogene; 2014 Jul; 33(28):3668-76. PubMed ID: 23995792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer.
    Choi C; Kwon J; Lim S; Helfman DM
    Oncotarget; 2016 Sep; 7(39):63466-63487. PubMed ID: 27563827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AKT drives sustained motility following MEK inhibition via promoting SNAIL and AXL in MDA-MB-231 LM2.
    Kwon J; Helfman DM; Kim MY
    Biochem Biophys Res Commun; 2020 Jul; 528(1):92-98. PubMed ID: 32456793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase.
    Scuto A; Zhang H; Zhao H; Rivera M; Yeatman TJ; Jove R; Torres-Roca JF
    Cancer Res; 2007 Nov; 67(21):10317-24. PubMed ID: 17974974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sur8/Shoc2 promotes cell motility and metastasis through activation of Ras-PI3K signaling.
    Kaduwal S; Jeong WJ; Park JC; Lee KH; Lee YM; Jeon SH; Lim YB; Min do S; Choi KY
    Oncotarget; 2015 Oct; 6(32):33091-105. PubMed ID: 26384305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells.
    Pollock CB; Shirasawa S; Sasazuki T; Kolch W; Dhillon AS
    Cancer Res; 2005 Feb; 65(4):1244-50. PubMed ID: 15735008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical role of tropomyosins in TGF-beta regulation of the actin cytoskeleton and cell motility in epithelial cells.
    Bakin AV; Safina A; Rinehart C; Daroqui C; Darbary H; Helfman DM
    Mol Biol Cell; 2004 Oct; 15(10):4682-94. PubMed ID: 15317845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin, insulin-like growth factor-I, and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells.
    Tsakiridis T; Tsiani E; Lekas P; Bergman A; Cherepanov V; Whiteside C; Downey GP
    Biochem Biophys Res Commun; 2001 Oct; 288(1):205-11. PubMed ID: 11594774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the extracellular signal-regulated kinase by complement C5b-9.
    Cybulsky AV; Takano T; Papillon J; Bijian K; Guillemette J
    Am J Physiol Renal Physiol; 2005 Sep; 289(3):F593-603. PubMed ID: 15855657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human diploid fibroblasts are resistant to MEK/ERK-mediated disruption of the actin cytoskeleton and invasiveness stimulated by Ras.
    Sukezane T; Oneyama C; Kakumoto K; Shibutani K; Hanafusa H; Akagi T
    Oncogene; 2005 Aug; 24(36):5648-55. PubMed ID: 16007212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
    Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway.
    Tsubaki M; Satou T; Itoh T; Imano M; Ogaki M; Yanae M; Nishida S
    Toxicol Appl Pharmacol; 2012 Mar; 259(3):402-10. PubMed ID: 22326785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation.
    Kim SE; Choi KY
    Cell Signal; 2007 Jul; 19(7):1554-64. PubMed ID: 17374561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular signal-regulated kinase activation during renal ischemia/reperfusion mediates focal adhesion dissolution and renal injury.
    Alderliesten M; de Graauw M; Oldenampsen J; Qin Y; Pont C; van Buren L; van de Water B
    Am J Pathol; 2007 Aug; 171(2):452-62. PubMed ID: 17620366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. γ-Enolase C-terminal peptide promotes cell survival and neurite outgrowth by activation of the PI3K/Akt and MAPK/ERK signalling pathways.
    Hafner A; Obermajer N; Kos J
    Biochem J; 2012 Apr; 443(2):439-50. PubMed ID: 22257123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis.
    Galante JM; Mortenson MM; Bowles TL; Virudachalam S; Bold RJ
    J Surg Res; 2009 Mar; 152(1):18-25. PubMed ID: 19062038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.